These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 32546972)
1. Dihydroartemisinin Inhibits the Proliferation of Leukemia Cells K562 by Suppressing PKM2 and GLUT1 Mediated Aerobic Glycolysis. Gao P; Shen S; Li X; Liu D; Meng Y; Liu Y; Zhu Y; Zhang J; Luo P; Gu L Drug Des Devel Ther; 2020; 14():2091-2100. PubMed ID: 32546972 [TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin represses esophageal cancer glycolysis by down-regulating pyruvate kinase M2. Li S; Huang P; Gan J; Ling X; Du X; Liao Y; Li L; Meng Y; Li Y; Bai Y Eur J Pharmacol; 2019 Jul; 854():232-239. PubMed ID: 31004604 [TBL] [Abstract][Full Text] [Related]
3. Oxidized ATM-mediated glycolysis enhancement in breast cancer-associated fibroblasts contributes to tumor invasion through lactate as metabolic coupling. Sun K; Tang S; Hou Y; Xi L; Chen Y; Yin J; Peng M; Zhao M; Cui X; Liu M EBioMedicine; 2019 Mar; 41():370-383. PubMed ID: 30799198 [TBL] [Abstract][Full Text] [Related]
4. Dihydroartemisinin breaks the positive feedback loop of YAP1 and GLUT1-mediated aerobic glycolysis to boost the CD8 Gao Y; Gong Y; Lu J; Yang Y; Zhang Y; Xiong Y; Shi X Biochem Pharmacol; 2024 Jul; 225():116294. PubMed ID: 38754557 [TBL] [Abstract][Full Text] [Related]
5. Apoptin Inhibits Glycolysis and Regulates Autophagy by Targeting Pyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells. Song G; Shang C; Zhu Y; Xiu Z; Li Y; Yang X; Ge C; Han J; Jin N; Li Y; Li X; Fang J Curr Cancer Drug Targets; 2024; 24(4):411-424. PubMed ID: 36284386 [TBL] [Abstract][Full Text] [Related]
6. PKM2-dependent glycolysis promotes the proliferation and migration of vascular smooth muscle cells during atherosclerosis. Zhao X; Tan F; Cao X; Cao Z; Li B; Shen Z; Tian Y Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):9-17. PubMed ID: 31867609 [TBL] [Abstract][Full Text] [Related]
7. Effects of shRNA-Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells. Yan XL; Zhang XB; Ao R; Guan L J Cell Biochem; 2017 Dec; 118(12):4792-4803. PubMed ID: 28543190 [TBL] [Abstract][Full Text] [Related]
9. Salidroside Induces Apoptosis in Human Gastric Cancer Cells via the Downregulation of ENO1/PKM2/GLUT1 Expression. Dai Z; Zhang X; Li W; Tang J; Pan T; Ma C; Guan Q Biol Pharm Bull; 2021 Nov; 44(11):1724-1731. PubMed ID: 34471002 [TBL] [Abstract][Full Text] [Related]
10. miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinoma. Liu AM; Xu Z; Shek FH; Wong KF; Lee NP; Poon RT; Chen J; Luk JM PLoS One; 2014; 9(1):e86872. PubMed ID: 24466275 [TBL] [Abstract][Full Text] [Related]
11. Tazarotene-Induced Gene 1 Interacts with DNAJC8 and Regulates Glycolysis in Cervical Cancer Cells. Wang CH; Shyu RY; Wu CC; Chen ML; Lee MC; Lin YY; Wang LK; Jiang SY; Tsai FM Mol Cells; 2018 Jun; 41(6):562-574. PubMed ID: 29902837 [TBL] [Abstract][Full Text] [Related]
12. GRP78 is implicated in the modulation of tumor aerobic glycolysis by promoting autophagic degradation of IKKβ. Li Z; Wang Y; Newton IP; Zhang L; Ji P; Li Z Cell Signal; 2015 Jun; 27(6):1237-45. PubMed ID: 25748049 [TBL] [Abstract][Full Text] [Related]
13. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells. Mi YJ; Geng GJ; Zou ZZ; Gao J; Luo XY; Liu Y; Li N; Li CL; Chen YQ; Yu XY; Jiang J PLoS One; 2015; 10(3):e0120426. PubMed ID: 25799586 [TBL] [Abstract][Full Text] [Related]
14. JMJD5 regulates PKM2 nuclear translocation and reprograms HIF-1α-mediated glucose metabolism. Wang HJ; Hsieh YJ; Cheng WC; Lin CP; Lin YS; Yang SF; Chen CC; Izumiya Y; Yu JS; Kung HJ; Wang WC Proc Natl Acad Sci U S A; 2014 Jan; 111(1):279-84. PubMed ID: 24344305 [TBL] [Abstract][Full Text] [Related]
15. Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment. Zhou Y; Huang Z; Su J; Li J; Zhao S; Wu L; Zhang J; He Y; Zhang G; Tao J; Zhou J; Chen X; Peng C Int J Cancer; 2020 Jul; 147(1):139-151. PubMed ID: 31652354 [TBL] [Abstract][Full Text] [Related]
16. Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis. Feng J; Dai W; Mao Y; Wu L; Li J; Chen K; Yu Q; Kong R; Li S; Zhang J; Ji J; Wu J; Mo W; Xu X; Guo C J Exp Clin Cancer Res; 2020 Jan; 39(1):24. PubMed ID: 32000827 [TBL] [Abstract][Full Text] [Related]
17. PKM2 promotes glucose metabolism through a let-7a-5p/Stat3/hnRNP-A1 regulatory feedback loop in breast cancer cells. Yao A; Xiang Y; Si YR; Fan LJ; Li JP; Li H; Guo W; He HX; Liang XJ; Tan Y; Bao LY; Liao XH J Cell Biochem; 2019 Apr; 120(4):6542-6554. PubMed ID: 30368881 [TBL] [Abstract][Full Text] [Related]
18. Tumor treating fields (TTFields) impairs aberrant glycolysis in glioblastoma as evaluated by [ Patel CB; Beinat C; Xie Y; Chang E; Gambhir SS Neoplasia; 2021 Jan; 23(1):58-67. PubMed ID: 33221711 [TBL] [Abstract][Full Text] [Related]
19. The mTOR Pathway Regulates PKM2 to Affect Glycolysis in Esophageal Squamous Cell Carcinoma. Xiaoyu H; Yiru Y; Shuisheng S; Keyan C; Zixing Y; Shanglin C; Yuan W; Dongming C; Wangliang Z; Xudong B; Jie M Technol Cancer Res Treat; 2018 Jan; 17():1533033818780063. PubMed ID: 29916308 [TBL] [Abstract][Full Text] [Related]
20. Pyruvate Kinase M2 Modulates Esophageal Squamous Cell Carcinoma Chemotherapy Response by Regulating the Pentose Phosphate Pathway. Fukuda S; Miyata H; Miyazaki Y; Makino T; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1461-8. PubMed ID: 25808097 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]